Pharmaceutical materials

Hot-Sale Peptide Ipamorelin CAS: 170851-70-4 with Factory Price
Basic information:
Alias: 46 claimed protein, Ipamorelin
CAS: 170851-70-4
Formula: C38H49N9O5
Appearance: White powder
Grade : Pharmaceutical Grade
Ipamorelinis a fascinating new muscle building discovery that is getting a lot of attention in the bodybuilding world. Like the GHRP-6 peptide (hormone releasing hexapeptide), it is a synthetic peptide that has powerful Hormone releasing properties. And these GH releasing properties are what is of interest to athletes and bodybuilders since they can make a tremendous difference in the amount of muscle you can grow and how quickly you burn fat.
Ipamorelin is an interesting peptide taken 300mcg twice daily or you could lower the dose for 3 times daily, side effects are head rushs, I would recommend taking this 30 minutes before workout ,with gear, Ipamorelin is a new and potent synthetic pentapeptide which has distinct and specific hormone (GH)-releasing properties. With the objective of investigating the effects on longitudinal bone growth rate , body weight , and GH release, Ipamorelin in different doses (0, 18, 90 and 450 μg/day) was injected three times daily for 15 days to test subjects, After intravital Tetracycline labelling on days 0, 6, and 13, LGR was determined by measuring the distance between the respective fluorescent bands in the proximal tibia metaphysis. Ipamorelin dose-dependently increased LGR from 42 μm/day in the vehicle group to 44, 50, and 52 μm/day in the treatment groups . There was also a pronounced and dose-dependent effect on body weight gain. The treatment did not affect total IGF-I levels, or serum markers of bone formation and resorption. The number of tartrate-resistant acid phosphatase-positive multinuclear cells in the metaphysis of the tibia did not change significantly with treatment. The responsiveness of the pituitary to a provocative i.v. dose of Ipamorelin or GHRH showed that the plasma GH response was marginally reduced , after Ipamorelin, but unchanged after GHRH. The pituitary GH content was unchanged by Ipamorelin treatment. Whether Ipamorelin or other GH secretagogues may have a place in the treatment of children with growth retardation requires demonstration in future clinical studies. Before closing Ipamorelin is the most selective GH releaser you can get.

Ipamorelin has been shown to be both highly potent and very selective in vivo and vitro situations, and has also demonstrated good safety and tolerability in human clinical studies. Research has shown that Ipamorelin is hormone specific which means that the pituitary hormones such as cortisol are unaffected. In one study, it was found that young female adult rats had increased bone mass due to 12 weeks of treatment with ipamorelin. This peptide compared to other Hormone Releasing Peptides ensures the benefits without having to deal with possible negative side effects.


至: Yuancheng(HK) Pharmaceutical Co.,Ltd
Your E-mail:

Send to other suppliers

Other supplier products

Pharmaceutical materials
Pharmaceutical materials
CAS 72-63-9 Metandienone ,Dianabol /
Pharmaceutical materials
CAS 145-13-1 Pregnenolone/

Same products

Pharmaceutical materials 卖方: Yuancheng(HK) Pharmaceutical Co.,Ltd
Pharmaceutical materials 卖方: Yuancheng(HK) Pharmaceutical Co.,Ltd
Pharmaceutical materials 卖方: Yuancheng(HK) Pharmaceutical Co.,Ltd
Pharmaceutical materials 卖方: Yuancheng(HK) Pharmaceutical Co.,Ltd
Pharmaceutical materials 卖方: Yuancheng(HK) Pharmaceutical Co.,Ltd